Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Feb 14, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC | NASDAQ | Diagnostics & Research | A | $50.25B | $629.35 | 1.97% | $1.45B | 49.48x | 1.17 | United States | 50 |
| LTM | LATAM AIRLINES GROUP SA | NYSE | Airlines | A | $36.09B | $59.71 | -2.48% | $1.88B | 18.47x | 20.11 | Chile | 40 |
| JLL | JONES LANG LASALLE INC | NYSE | Real Estate Services | A | $13.65B | $289.15 | 3.21% | $1.16B | 21.71x | 1.38 | United States | 45 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $10.11B | $166.31 | 0.01% | $182.64M | -27.76x | 1.87 | Ireland | 16 |
| BCO | BRINKS CO | NYSE | Security & Protection Services | A | $5.43B | $130.69 | 1.24% | $806.70M | 32.75x | 24.42 | United States | 44 |
| VISN | VISTANCE NETWORKS INC | NASDAQ | Communication Equipment | A | $4.25B | $19.20 | 2.45% | $1.70B | 4.68x | -3.84 | United States | 24 |
| RSI | RUSH STREET INTERACTIVE INC | NYSE | Gambling | A | $3.68B | $16.03 | 0.88% | -$33.04M | 48.58x | 2.40 | United States | 51 |
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | A | $2.83B | $35.77 | 1.76% | $57.00M | 91.72x | 0.09 | United States | 45 |
| DBD | DIEBOLD NIXDORF INC | NYSE | Software - Application | A | $2.82B | $80.30 | 6.23% | $331.90M | 31.25x | 2.50 | United States | 42 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.05B | $157.96 | -2.24% | $301.16M | 9.15x | 1.82 | United States | 54 |
| HLMN | HILLMAN SOLUTIONS CORP | NASDAQ | Tools & Accessories | A | $1.98B | $10.06 | 0.70% | $249.21M | 50.30x | 0.95 | United States | 41 |
| DFIN | DONNELLEY FINANCIAL SOLUTIONS INC | NYSE | Capital Markets | A | $1.04B | $39.12 | 1.85% | $119.00M | 35.24x | 0.93 | United States | 42 |
| TBLA | TABOOLACOM LTD | NASDAQ | Internet Content & Information | A | $968.43M | $3.36 | 0.60% | $137.29M | 42.00x | 0.68 | United States | 45 |
| UVE | UNIVERSAL INSURANCE HOLDINGS INC | NYSE | Insurance - Property & Casualty | A | $874.28M | $31.17 | -2.35% | $174.52M | 7.12x | 5.24 | United States | 39 |
| MNTN | MNTN INC | NYSE | Software - Application | A | $752.00M | $10.27 | -6.21% | N/A | N/A | 0.26 | United States | 13 |
| NRDS | NERDWALLET INC | NASDAQ | Internet Content & Information | A | $684.23M | $9.41 | 2.62% | $98.00M | 9.70x | 0.23 | United States | 55 |
| BWMN | BOWMAN CONSULTING GROUP LTD | NASDAQ | Engineering & Construction | A | $586.52M | $33.76 | 1.75% | $38.00M | 34.45x | 0.95 | United States | 54 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $473.38M | $3.73 | -0.27% | $18.04M | -31.08x | 0.49 | United States | 20 |
| FENC | FENNEC PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $236.74M | $8.42 | 2.68% | -$4.53M | -33.68x | -11.97 | United States | 30 |
| LTRX | LANTRONIX INC | NASDAQ | Communication Equipment | A | $217.51M | $5.48 | 3.01% | -$4.74M | -23.83x | 0.64 | United States | 17 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $200.76M | $24.26 | 4.08% | $13.13M | 22.67x | 0.21 | United States | 51 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $153.33M | $7.54 | 1.62% | $24.16M | 29.00x | 0.78 | United States | 45 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.